Cartesian Therapeutics
RNAC
RNAC
44 hedge funds and large institutions have $37.3M invested in Cartesian Therapeutics in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
-12
Holders Change %
-21.43%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
6
Reduced
19
Closed
19
Calls
$5K
Puts
$9K
Net Calls
-$4K
Net Calls Change
+$17K
Top Buyers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$858K |
2 |
Millennium Management
New York
|
+$730K |
3 |
Renaissance Technologies
New York
|
+$419K |
4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$275K |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$197K |
Top Sellers
1 |
BlackRock
New York
|
-$1.83M |
2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$667K |
3 |
![]()
JPMorgan Chase & Co
New York
|
-$606K |
4 |
State Street
Boston,
Massachusetts
|
-$535K |
5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$504K |